The FDA is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a Kaiser Health News review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers. Since 2013, drugmakers have recalled about 8,000 medicines and the flawed products contained everything from dangerous bacteria or tiny glass particles to mold. During that same period, 65 drug-making facilities recalled nearly 300 products within 12 months of passing an FDA inspection. The story was co-published by ABC News and featured on Good Morning America.